DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $24,004,000 | -45.8% | 1,190,676 | +0.3% | 0.00% | -50.0% |
| Q2 2021 | $44,324,000 | +54.4% | 1,187,695 | +5.8% | 0.01% | +50.0% |
| Q1 2021 | $28,702,000 | +26.1% | 1,122,506 | +8.7% | 0.00% | 0.0% |
| Q4 2020 | $22,753,000 | +33.9% | 1,032,838 | +9.4% | 0.00% | +33.3% |
| Q3 2020 | $16,991,000 | -28.8% | 944,479 | +0.5% | 0.00% | -40.0% |
| Q2 2020 | $23,869,000 | +56.1% | 939,743 | +12.9% | 0.01% | +25.0% |
| Q1 2020 | $15,289,000 | -55.8% | 832,329 | -47.0% | 0.00% | 0.0% |
| Q4 2019 | $34,584,000 | +233.1% | 1,569,860 | +117.1% | 0.00% | +100.0% |
| Q3 2019 | $10,384,000 | -7.2% | 723,125 | +1.7% | 0.00% | -33.3% |
| Q2 2019 | $11,193,000 | +17.0% | 710,713 | +8.8% | 0.00% | +50.0% |
| Q1 2019 | $9,570,000 | -19.3% | 653,279 | -41.1% | 0.00% | 0.0% |
| Q4 2018 | $11,864,000 | +74.3% | 1,109,914 | +148.9% | 0.00% | 0.0% |
| Q3 2018 | $6,805,000 | +84.3% | 445,945 | +47.9% | 0.00% | +100.0% |
| Q2 2018 | $3,693,000 | +139.2% | 301,511 | +86.6% | 0.00% | 0.0% |
| Q1 2018 | $1,544,000 | +86.5% | 161,577 | +76.1% | 0.00% | – |
| Q4 2017 | $828,000 | +57.1% | 91,737 | 0.0% | 0.00% | – |
| Q3 2017 | $527,000 | +101.1% | 91,737 | +10.9% | 0.00% | – |
| Q2 2017 | $262,000 | -10.3% | 82,690 | -3.8% | 0.00% | – |
| Q1 2017 | $292,000 | +18.7% | 85,950 | +0.5% | 0.00% | – |
| Q4 2016 | $246,000 | -50.9% | 85,506 | +0.3% | 0.00% | – |
| Q3 2016 | $501,000 | +96.5% | 85,210 | +0.1% | 0.00% | – |
| Q2 2016 | $255,000 | -53.1% | 85,136 | -16.1% | 0.00% | – |
| Q1 2016 | $544,000 | -54.2% | 101,528 | +1.4% | 0.00% | -100.0% |
| Q4 2015 | $1,188,000 | +47.2% | 100,157 | +1.8% | 0.00% | – |
| Q3 2015 | $807,000 | -38.1% | 98,388 | +5.2% | 0.00% | -100.0% |
| Q2 2015 | $1,304,000 | -14.5% | 93,529 | +47.3% | 0.00% | 0.0% |
| Q1 2015 | $1,525,000 | +64.9% | 63,497 | +13.0% | 0.00% | 0.0% |
| Q4 2014 | $925,000 | +80.3% | 56,205 | +39.5% | 0.00% | – |
| Q3 2014 | $513,000 | -33.8% | 40,299 | +17.2% | 0.00% | -100.0% |
| Q2 2014 | $775,000 | -19.5% | 34,380 | +0.8% | 0.00% | 0.0% |
| Q1 2014 | $963,000 | – | 34,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |